Bydureon
Active substance: exenatide
exenatide
Centralised EU authorisationWithdrawn
Marketing holder: AstraZeneca AB
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 |
|
| US 4 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c4-b952-7a42-a686-fc31d7987ca6,01a120c5-51ec-752f-972d-c1ccc04bf18a;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-a0ab-71e2-a58e-ebbcf88f7360,01a12090-7dfb-797b-9a8a-b80190281e02,01a12090-7e0a-7105-8266-8abc3191ec00,01a12099-72ff-7518-93e9-b73356d45ee1;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/002020
- Registration status
- Withdrawn
- ATC code
- A10BJ01
Sources
- product · EMA · EMEA/H/C/002020 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002020 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002020 · Verified 2026-10-09